BioProcess360

We're pleased to welcome Steve Tingley, who joins us as a Commercial Strategy Business Consultant.

Steve has more than four decades in the bioprocessing industry, most recently serving as Vice President of Sales at Repligen. He has broad bioprocessing experience, notably with deep domain expertise in downstream bioprocessing, including single-use technologies, filtration and chromatography, particularly protein A purification.

Throughout his career, Steve has led the development of several key novel technologies and executed strong go-to-market strategies, making him a highly respected figure in the industry.

"The bioprocessing industry continues to evolve rapidly, at the same time it is an industry which struggles to adopt new technologies easily. Yet it is exactly these emerging technologies that hold the promise of further transforming how biologics are developed and manufactured," said Steve Tingley. "Successfully commercializing even the most promising new technologies is a massive challenge for the entrepreneurs in this space. I am excited to work alongside the Bioprocess360 Partners team to help identify and support the most promising innovations that will help shape the future of biomanufacturing."

Chris Major, Founding Partner at Bioprocess360, added, "We're delighted to bring Steve on board to partner with us in helping to guide our investments. Steve brings a wealth of real-world experience in helping us create successful commercial strategies. We have a strong history of working successfully together, and we look forward to continuing to bring novel, life-improving bioprocessing technologies to the industry."

We welcome Steve to the team!